Why Fast-paced Mover Clover Health Investments ( CLOV ) Is a Great Choice for Value Investors
Clover Health Investments (CLOV) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
CLOV Q3 Earnings Miss, Stock Falls on Raised Insurance BER View
Clover Health's Q3 sales soar 50%, but higher Insurance costs and a raised BER outlook weigh on investor sentiment.
Super Micro Computer Posts Downbeat Q1 Results, Joins Pinterest, Axon Enterprise And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Arista Networks ( NYSE:ANET ) , Advanced Micro Devices ( NASDAQ:AMD )
U.S. stock futures were lower this morning, with the Dow futures falling more than 50 points on Wednesday. Shares of Super Micro Computer Inc ( NASDAQ:SMCI ) fell sharply in pre-market trading after the company reported worse-than-expected first-quarter financial results and issued second-quarter ...
Why Teradata Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Akari Therapeutics ( NASDAQ:AKTX ) , Applied Digital ( NASDAQ:APLD )
Shares of Teradata Corp ( NYSE:TDC ) rose sharply in pre-market trading after the company reported better-than-expected third-quarter financial results and raised its FY25 EPS guidance above estimates. Also, the company issued fourth-quarter EPS guidance above estimates.
Clover Health Investments, Corp. ( CLOV ) Reports Break-Even Earnings for Q3
Clover Health Investments (CLOV) delivered earnings and revenue surprises of -100.00% and +4.47%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More - Palantir Technologies ( NASDAQ:PLTR )
Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday. Here's a look at the names most likely to be on individual investors' radars. CIFR stock is soaring. Watch the real-time price action here.
Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service - Clover Health Investments ( NASDAQ:CLOV )
WILMINGTON, Del., Oct. 31, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. ( NASDAQ:CLOV ) ( "Clover," "Clover Health" or the "Company" ) today announced that Chelsea Clinton, the longest-serving member of its Board of Directors, having joined the Board in early 2017, will conclude ...
Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service
WILMINGTON, Del., Oct. 31, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. ( Nasdaq: CLOV ) ( "Clover," "Clover Health" or the "Company" ) today announced that Chelsea Clinton, the longest-serving member of its Board of Directors, having joined the Board in early 2017, will conclude ...
Primary Care Physician Use of Counterpart Assistant ( CA ) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations
New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease. New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease.
Cigna Q3 Earnings Beat Estimates on Evernorth Health Unit Strength
CI's Q3 earnings and revenues beat estimates as Evernorth Health Services powers growth despite healthcare headwinds.
Ford, Inhibrx Biosciences, Comfort Systems, Western Union And Other Big Stocks Moving Higher On Friday - Bitfarms ( NASDAQ:BITF ) , Cipher Mining ( NASDAQ:CIFR )
U.S. stocks were higher, with the Dow Jones index gaining around 350 points on Friday. Shares of Ford Motor Company ( NYSE:F ) rose sharply during Friday's session after the company reported third-quarter adjusted EPS and sales above estimates.
Clover Health Investments ( CLOV ) Upgraded to Buy: Here's What You Should Know
Clover Health Investments (CLOV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference
WILMINGTON, Del., Oct. 22, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. ( Nasdaq: CLOV ) ( "Clover," "Clover Health" or the "Company" ) , today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 UBS Global Healthcare Conference on Tuesday, November ...
General Motors Posts Upbeat Q3 Results, Joins Halliburton, Danaher, Crown Holdings And Other Big Stocks Moving Higher On Tuesday - Beyond Meat ( NASDAQ:BYND ) , Crown Holdings ( NYSE:CCK )
U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Tuesday. Shares of General Motors Company ( NYSE:GM ) rose sharply during Tuesday's session after the company reported better-than-expected third-quarter financial results and raised FY25 adjusted EPS outlook.
Clover Health's 2026 Medicare Advantage Plans Champion Affordability and Choice - Clover Health Investments ( NASDAQ:CLOV )
JERSEY CITY, N.J., Oct. 15, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. ( NASDAQ:CLOV ) ( "Clover," "Clover Health" or the "Company" ) , a physician enablement company dedicated to bringing access to great healthcare to everyone on Medicare, today announced its 2026 Medicare ...
Clover Health's 2026 Medicare Advantage Plans Champion Affordability and Choice
The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable Value The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable Value ...
Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners
Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans ...
Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027 - Clover Health Investments ( NASDAQ:CLOV )
WILMINGTON, Del., Oct. 09, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. ( NASDAQ:CLOV ) ( "Clover," "Clover Health" or the "Company" ) , a physician enablement company dedicated to bringing access to great healthcare to everyone on Medicare, today commented on the Centers for ...
Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027
Company underscores differentiated business model. reiterates confidence in its ability to drive above-market membership growth and increasing Adjusted EBITDA profitability1 through 2027, independent of Star ratings ...
Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant
New VP Blaine Lindsey to Drive National Enterprise Growth. Gulf Region President Shannon Jacobs to Scale Operations in High-Need Markets New VP Blaine Lindsey to Drive National Enterprise Growth. Gulf Region President Shannon Jacobs to Scale Operations in High-Need Markets ...
Is Clover Health Investments ( CLOV ) Outperforming Other Medical Stocks This Year?
Here is how Clover Health Investments, Corp. (CLOV) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.
Fast-paced Momentum Stock Clover Health Investments ( CLOV ) Is Still Trading at a Bargain
Clover Health Investments (CLOV) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Clover Health Celebrates the Election of Dr. Ian Duncan, Clover MA Board Member, as the 2025-2026 President-Elect and Vice-Chair of the Society of Actuaries
Dr. Duncan's appointment to this prestigious role recognizes his extraordinary contributions to the actuarial profession and healthcare innovation over three decades Dr. Duncan's appointment to this prestigious role recognizes his extraordinary contributions to the actuarial profession and ...
Clover Health Launches New Portal Availity® Essentials™ to Empower Providers and Improve the Patient Experience
Clover Health Continues to Invest in Streamlining Provider Workflows and Reducing Administrative Burden Through Technology and Operational Improvements Clover Health Continues to Invest in Streamlining Provider Workflows and Reducing Administrative Burden Through Technology and Operational ...
Counterpart Health Launches Integrated Scribing, Supercharging Counterpart Assistant with Smarter, Seamless Scribing Built for Value-Based Care
The latest AI-powered feature in Counterpart Assistant streamlines documentation, enhances physician workflows, and raises the bar for value-based care across practice settings at no additional cost to users The latest AI-powered feature in Counterpart Assistant streamlines documentation, ...
Clover Health CEO Andrew Toy Testifies Before Congress on the Transformative Role of AI in Healthcare, Highlights how Clover is Leading the Way
WASHINGTON, D.C., Sept. 03, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. ( Nasdaq: CLOV ) ( "Clover," "Clover Health" or the "Company" ) - Clover Health CEO Andrew Toy today had the honor to deliver testimony before the U.S. House of Representatives Committee on Energy and Commerce ...
Here's Why You Should Add CLOV Stock to Your Portfolio Now
Clover's strong membership growth, rising revenues, and first-half EBITDA profitability highlight its tech-driven Medicare Advantage edge.
Bears are Losing Control Over Clover Health Investments ( CLOV ) , Here's Why It's a 'Buy' Now
Clover Health Investments (CLOV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's ...
Chamath Palihapitiya Returns To SPACs: Past 18 Deals, Investments Average Loss Of 14% - Lemonade ( NYSE:LMND ) , Clover Health Investments ( NASDAQ:CLOV )
Chamath Palihapitiya is back with a new SPAC filing. A look back at the 18 SPACs Chamath Palihapitiya has been involved with and the return for investors. Get the exact trades and sectors to target before August's biggest earnings-driven market moves. Details here →
'SPAC King' Chamath Palihapitiya Returns With $250 Million 'American Exceptionalism' Deal Targeting AI, Energy, Defense - Clover Health Investments ( NASDAQ:CLOV ) , Opendoor Technologies ( NASDAQ:OPEN )
Venture capitalist Chamath Palihapitiya, once dubbed the "SPAC King," is returning to Wall Street with a new blank-check deal. American Exceptionalism Acquisition Corp. filed a Form S-1 on Monday with the U.S. Securities and Exchange Commission, seeking to raise $250 million through an initial ...
Is the Market Bullish or Bearish on Clover Health Investments? - Clover Health Investments ( NASDAQ:CLOV )
Clover Health Investments's CLOV short percent of float has risen 12.43% since its last report. The company recently reported that it has 41.04 million shares sold short, which is 10.04% of all regular shares that are available for trading.
CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View
Clover Health's Q2 revenues rise 34%, but raised Insurance BER guidance and margin pressures cause shares to tumble post-earnings.
Clover Health ( CLOV ) Q2 Sales Up 34%
Clover Health Investments ( NASDAQ:CLOV ) , a technology-focused Medicare Advantage insurer, reported its Q2 2025 results on August 5, 2025. The most notable news was robust revenue growth, with GAAP sales climbing to $477.6 million-surpassing analyst expectations of $468.3 million ( GAAP ) .
Clover Health Investments, Corp. ( CLOV ) Q2 Earnings Meet Estimates
Clover Health Investments (CLOV) delivered earnings and revenue surprises of 0.00% and -1.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease
New whitepaper shows that a relationship with a primary care physician ( "PCP" ) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease ( "COPD" ) diagnosis, increased specialty care, and meaningful reductions in hospitalizations ( 15% lower ) and ...
Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease - Clover Health Investments ( NASDAQ:CLOV )
New whitepaper shows that a relationship with a primary care physician ( "PCP" ) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease ( "COPD" ) diagnosis, increased specialty care, and meaningful reductions in hospitalizations ( 15% lower ) and ...
Clover Health Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?
CLOV's second-quarter results are likely to reflect strong Medicare Advantage membership growth and expansion and deeper integration of Clover Assistant.
Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution
WILMINGTON, Del., July 29, 2025 ( GLOBE NEWSWIRE ) -- Counterpart Health, Inc. ( "Counterpart" ) , a wholly owned subsidiary of Clover Health Investments, Corp. ( Nasdaq: CLOV ) ( "Clover," "Clover Health" or the "Company" ) and a leading AI-powered physician-enablement platform, today announced ...
Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution - Clover Health Investments ( NASDAQ:CLOV )
WILMINGTON, Del., July 29, 2025 ( GLOBE NEWSWIRE ) -- Counterpart Health, Inc. ( "Counterpart" ) , a wholly owned subsidiary of Clover Health Investments, Corp.
Why Medpace Shares Are Trading Higher By 45%; Here Are 20 Stocks Moving Premarket - ReAlpha Tech ( NASDAQ:AIRE ) , Agilysys ( NASDAQ:AGYS )
Shares of Medpace Holdings, Inc. MEDP rose sharply in pre-market trading after the company reported strong financial results for the second quarter and raised its full-year guidance. Medpace expects 2025 revenue to be in the range of $2.42 billion to $2.52 billion, up from prior guidance of $2.14 ...
Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference
WILMINGTON, Del., July 21, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. ( Nasdaq: CLOV ) ( "Clover," "Clover Health" or the "Company" ) , today announced that its Chief Financial Officer, Peter Kuipers, will present at the Canaccord Genuity 45th Annual Growth Conference on ...
Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference - Clover Health Investments ( NASDAQ:CLOV )
WILMINGTON, Del., July 21, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. CLOV ( "Clover," "Clover Health" or the "Company" ) , today announced that its Chief Financial Officer, Peter Kuipers, will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, ...
What's Going On With Clover Health Stock? - Clover Health Investments ( NASDAQ:CLOV )
Clover shares are rising Tuesday, adding to strong gains over the past week. The company schedules its second-quarter earnings for after the market close on Aug. 5. Up Next: Get 5 Dark Horse Stocks Wall Street Is Quietly Loading Up On Clover Health Investments, Corp.
Clover Health to Report Second Quarter 2025 Financial Results on August 5, 2025
WILMINGTON, Del., July 08, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. ( Nasdaq: CLOV ) ( "Clover," "Clover Health" or the "Company" ) , today announced that it will release its financial results after the market closes on Tuesday, August 5, 2025.
Centene Pulls 2025 Guidance as Marketplace Growth Falters
CNC pulls its 2025 forecast after a $1.8B risk adjustment shortfall. Also, weak Marketplace growth shakes investor confidence.
Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment
CI to cover RhinAer for chronic rhinitis starting Sept. 15, expanding access to a minimally invasive, office-based treatment.
Clover Health Set to Join Russell 3000® Index - Clover Health Investments ( NASDAQ:CLOV )
WILMINGTON, Del., June 30, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. CLOV ( "Clover Health" ) , announced that it is set to join the broad-market Russell 3000® Index, effective after the US market opens today, June 30, 2025, as part of the 2025 Russell indexes reconstitution.
Here's Why MOH Shares Are Attracting Prudent Investors Now
Molina Healthcare draws investor interest with strong earnings growth, contract wins and premium revenue momentum despite rising costs.
Chamath Palihapitiya Asks If He Should Launch Another SPAC-70% Say No, Users Warn of Past Failures: 'No Crying In The Casino!' - Clover Health Investments ( NASDAQ:CLOV ) , Opendoor Technologies ( NASDAQ:OPEN )
Venture capitalist Chamath Palihapitiya sparked debate on social media by polling followers about launching another Special Purpose Acquisition Company ( SPAC ) , with 70.7% of 55,458 respondents voting "no" amid warnings about his troubled SPAC track record.
Ensign Enhances Presence With 3 New Acquisitions in 2 States
ENSG adds three skilled nursing facilities in Idaho and California, boosting its U.S. footprint and fueling future growth.
